Moses Rodriguez

Active 1980–2025

152
Papers
26,548
Citations
93
h-index
149
i10-index

Citations

Citations per year for Moses Rodriguez1983: 1 citations1984: 7 citations1985: 4 citations1986: 12 citations1987: 8 citations1988: 11 citations1989: 8 citations1990: 21 citations1991: 19 citations1992: 29 citations1993: 31 citations1994: 36 citations1995: 54 citations1996: 38 citations1997: 57 citations1998: 132 citations1999: 152 citations2000: 161 citations2001: 197 citations2002: 238 citations2003: 223 citations2004: 247 citations2005: 247 citations2006: 242 citations2007: 290 citations2008: 200 citations2009: 214 citations2010: 196 citations2011: 189 citations2012: 214 citations2013: 191 citations2014: 153 citations2015: 177 citations2016: 128 citations2017: 178 citations2018: 180 citations2019: 605 citations2020: 578 citations2021: 564 citations2022: 498 citations2023: 316 citations2024: 433 citations2025: 213 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,526 citing papers, 28.6% of this breakdownGermany: 664 citing papers, 7.5% of this breakdownUnited Kingdom: 653 citing papers, 7.4% of this breakdownItaly: 517 citing papers, 5.9% of this breakdownCanada: 483 citing papers, 5.5% of this breakdownChina: 358 citing papers, 4.1% of this breakdownFrance: 293 citing papers, 3.3% of this breakdownNetherlands: 272 citing papers, 3.1% of this breakdownSpain: 271 citing papers, 3.1% of this breakdownAustralia: 240 citing papers, 2.7% of this breakdownAustria: 224 citing papers, 2.5% of this breakdownSwitzerland: 207 citing papers, 2.3% of this breakdown
0%28.6%Other 24%

Fields

  • Medicine60.8%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Neuroscience12.4%
  • Immunology and Microbiology6.3%
  • Agricultural and Biological Sciences1.2%
  • Nursing0.7%
  • Other2.4%

Topics

  • Multiple Sclerosis Research Studies16.5%
  • Peripheral Neuropathies and Disorders5.4%
  • Neuroinflammation and Neurodegeneration Mechanisms5.2%
  • Neurogenesis and neuroplasticity mechanisms3.9%
  • Gut microbiota and health3.1%
  • Systemic Lupus Erythematosus Research2.1%
  • Other63.8%

Coauthors

All papers

Open in search
  1. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

    Authors: , , , , , , , , , , , , , , , - Scientific Reports 2016 cited by 972

  2. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

    Authors: , , , , , - Annals of Neurology 2000 cited by 3,340

  3. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

    Authors: , , , , , , , , , , , , , , - Multiple Sclerosis Journal 2012 cited by 267

  4. Multiple Sclerosis

    Authors: , , , - New England Journal of Medicine 2000 cited by 2,887

  5. Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rory Mitchell, Sue Fleetwood‐Walker, David A. Lyons, Siddharthan Chandran, Hans Lassmann, Bruce D. Trapp, Don Mahad - Acta Neuropathologica 2020 cited by 93

  6. Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease

    Authors: , , , , , , , , , , , , , , - Cell Reports 2017 cited by 268

  7. Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular Cancer Research 2022 cited by 60

  8. Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric Multiple Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2020 cited by 115

  9. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease

    Authors: , , , , , , , , - Annals of Neurology 1999 cited by 890

  10. Multiple Sclerosis

    Authors: , , - Neurologic Clinics 2017 cited by 146

  11. Gut microbiota composition and relapse risk in pediatric MS: A pilot study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the Neurological Sciences 2016 cited by 173

  12. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ling Shen, Hong Quach, Diana Quach, Jan Hillert, Maria Bäärnhielm, Anna Karin Hedström, Tomas Olsson, Ingrid Kockum, Lars Alfredsson, Catherine Metayer, Catherine Schaefer, Lisa F. Barcellos, Emmanuelle Waubant, Jennifer Graves, Tanuja Chitnis, Amy Waldman, Timothy Loetze, Teri Schreiner, Anita Belman, Benjamin Greenberg, Bianca Weinstock‐Guttman, Gregory Aaen, Jan Mendelt Tillema, Janace Hart, Stacy J. Caillier, Jayne Ness, Yolanda Harris, Jennifer Rubin, Meghan Candee, Lauren Krupp, Mark Gorman, Lina Benson, Moses Rodriguez, Soe Mar, Ilana Kahn, John Rose, Shelly Roalstad, T. Charles Casper, Emmanuelle Waubant - Neurology 2017 cited by 163

  13. Surface plasmon resonance for high‐throughput ligand screening of membrane‐bound proteins

    Authors: , , , , , , - Biotechnology Journal 2009 cited by 129

  14. Remyelination in multiple sclerosis

    Authors: , , , - Multiple Sclerosis Journal 1997 cited by 192

  15. Common viruses associated with lower pediatric multiple sclerosis risk

    Authors: , , , , , , , , , , , , , , , , , - Neurology 2011 cited by 166

  16. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis

    Authors: , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2015 cited by 100

  17. Improved relapse recovery in paediatric compared to adult multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Brain 2020 cited by 90

  18. Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Soe Mar, Manikum Moodley, Jayne Ness, Moses Rodriguez, John Rose, Teri Schreiner, Jan‐Mendelt Tillema, Michael Waltz, T. Charles Casper, Emmanuelle Waubant - Neurology 2018 cited by 86

  19. Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Pediatric Neurology 2023 cited by 25

  20. Efficient central nervous system remyelination requires T cells

    Authors: , , - Annals of Neurology 2003 cited by 188

  21. Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica Communications 2023 cited by 20

  22. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis

    Authors: , , , - Brain Pathology 1996 cited by 741

  23. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions

    Authors: , , , , , - Brain 1999 cited by 459

  24. The relevance of animal models in multiple sclerosis research

    Authors: , , , , , - Pathophysiology 2010 cited by 293